The embodiments described herein relate generally to medical devices for therapeutic electrical energy delivery, and more particularly to systems and methods for delivering electrical energy in the context of ablating tissue rapidly and selectively by the application of suitably timed pulsed voltages that generate irreversible electroporation of cell membranes.
The past two decades have seen advances in the technique of electroporation as it has progressed from the laboratory to clinical applications. Known methods include applying brief, high voltage DC pulses to tissue, thereby generating locally high electric fields, typically in the range of hundreds of Volts/centimeter. The electric fields disrupt cell membranes by generating pores in the cell membrane, which subsequently destroys the cell membrane and the cell. While the precise mechanism of this electrically-driven pore generation (or electroporation) awaits a detailed understanding, it is thought that the application of relatively large electric fields generates instabilities in the phospholipid bilayers in cell membranes, as well as mitochondria, causing the occurrence of a distribution of local gaps or pores in the membrane. If the applied electric field at the membrane exceeds a threshold value, typically dependent on cell size, the electroporation is irreversible and the pores remain open, permitting exchange of material across the membrane and leading to apoptosis or cell death. Subsequently, the surrounding tissue heals in a natural process.
While pulsed DC voltages are known to drive electroporation under the right circumstances, the examples of electroporation applications in medicine and delivery methods described in the prior art do not discuss specificity of how electrodes are selected to accomplish the desired ablation. For example, some known catheters and systems include a single multi-electrode catheter in which certain electrodes receive a voltage signal having a first polarity and other electrodes receive a voltage signal having the opposite polarity. Accordingly, to minimize the risk of dielectric breakdown within the catheter, such known catheters typically include substantial insulation (e.g., around the leads), thus increasing the size and limiting the flexibility of the catheter. Some known catheters configured to produce voltage pulses of up to 5 kV include catheter leads having an insulation of as much as 0.2 mm and an overall size of about 14 French (4.67 mm).
There is a need for selective energy delivery for electroporation and its modulation in various tissue types, as well as pulses that permit rapid action and completion of therapy delivery. This need includes methods and apparatus for placement and therapy delivery from the same device or a set of devices, especially in the context of ablation therapy for cardiac arrhythmias with epicardial catheter devices. There is a need for thin, flexible, atraumatic devices that can, at the same time, effectively deliver high DC voltage electroporation ablation therapy selectively to tissue in regions of interest. Such more selective and effective electroporation delivery methods can broaden the areas of clinical application of electroporation including therapeutic treatment of a variety of cardiac arrhythmias.
Catheter systems, tools and methods are disclosed for the selective and rapid application of DC voltage to drive electroporation. In some embodiments, an apparatus includes a voltage pulse generator and an electrode controller. The voltage pulse generator is configured to produce a pulsed voltage waveform. The electrode controller is configured to be operably coupled to the voltage pulse generator. The electrode controller includes a first output port and a second output port. The first output port is configured to be operatively coupled to a first medical device including a first set of electrodes, and the second output port is configured to be operatively coupled to a second medical device including a second set of electrodes. The electrode controller includes a selection module and a pulse delivery module. The selection module is configured to select at least a first electrode from the first set of electrodes and identify at least the first electrode as an anode. The selection module is configured to select at least a second electrode from the second set of electrodes and identify at least the second electrode as a cathode. The pulse delivery module is configured to deliver a first output signal having a first polarity and being associated with the pulsed voltage waveform to the first output port for application to the first electrode. The pulse delivery module is configured to deliver a second output signal having a second polarity opposite the first polarity and being associated with the pulsed voltage waveform to the second output port for application to the second electrode.
Systems and methods are disclosed for the selective and rapid application of DC voltage to drive electroporation. In some embodiments, an irreversible electroporation system includes a DC voltage/signal generator and a controller capable of being configured to apply voltages to a selected multiplicity or a subset of electrodes, with anode and cathode subsets being selected independently on distinct medical devices. The controller is additionally capable of applying control inputs whereby selected pairs of anode-cathode subsets of electrodes can be sequentially updated based on a pre-determined sequence.
In some embodiments, an irreversible electroporation system includes a DC voltage/signal generator and a controller capable of being configured to apply voltages to a selected multiplicity or a subset of electrodes, with independent subset selections for anode and cathode electrode selections on distinct catheter devices respectively. Further, the controller is capable of applying control inputs whereby selected pairs of anode-cathode subsets of electrodes can be sequentially updated based on a pre-determined sequence. The generator can output waveforms that can be selected to generate a sequence of voltage pulses in either monophasic or biphasic forms and with either constant or progressively changing amplitudes.
In some embodiments, an apparatus includes a voltage pulse generator and an electrode controller. The voltage pulse generator is configured to produce a pulsed voltage waveform. The electrode controller is configured to be operably coupled to the voltage pulse generator. The electrode controller includes a first output port and a second output port. The first output port is configured to be operatively coupled to a first medical device including a first set of electrodes, and the second output port is configured to be operatively coupled to a second medical device including a second set of electrodes. The electrode controller includes a selection module and a pulse delivery module. The selection module is configured to select at least a first electrode from the first set of electrodes and identify at least the first electrode as an anode. The selection module is configured to select at least a second electrode from the second set of electrodes and identify at least the second electrode as a cathode. The pulse delivery module is configured to deliver a first output signal having a first polarity and being associated with the pulsed voltage waveform to the first output port for application to the first electrode. The pulse delivery module is configured to deliver a second output signal having a second polarity opposite the first polarity and being associated with the pulsed voltage waveform to the second output port for application to the second electrode.
In some embodiments, an apparatus includes a voltage pulse generator and an electrode controller. The voltage pulse generator is configured to produce a pulsed voltage waveform. The electrode controller is configured to be operably coupled to the voltage pulse generator. The electrode controller includes a first output port and a second output port, the first output port configured to be operatively coupled to a first medical device including a first set of electrodes, the second output port configured to be operatively coupled to a second medical device including a second set of electrodes. The electrode controller includes a selection module and a pulse delivery module. The selection module is configured to select a set of anode/cathode pairs, each anode selected being only in the first plurality of electrodes, each cathode selected being only in the second plurality of electrodes. The pulse delivery module is configured to deliver a first output signal having a first polarity and associated with the pulsed voltage waveform to the first output port for application to each anode selected. The pulse delivery module is configured to deliver a second output signal having a second polarity opposite the first polarity and associated with the pulsed voltage waveform to the second output port for application to each cathode selected. The pulse delivery module is configured to deliver the first output signal and the second output signal to the plurality of anode/cathode pairs according to a sequential pattern.
Methods of control and DC voltage application from a generator capable of selective excitation of sets of electrodes are also disclosed herein. In some embodiments, a method includes identifying, via a selection module of an electrode controller, a set of anode/cathode pairs, each anode selected being only in a first set of electrodes of a first multi-electrode catheter, each cathode selected being only in a second set of electrodes of a second multi-electrode catheter. The first multi-electrode catheter and the second multi-electrode catheter are configured to collectively surround a portion of a heart. A pacing signal is conveyed to a pacing lead configured to be operatively coupled to the heart. The method includes receiving, at a feedback module, an electrocardiograph signal associated with a function of the heart. The method includes delivering, via a pulse delivery module of the electrode controller, a first output signal having a first polarity to each anode selected, and delivering, via the pulse delivery module, a second output signal having a second polarity opposite the first polarity to each cathode selected. The first output signal and the second output signal are delivered according to a sequential pattern.
In some embodiments, a non-transitory processor readable medium storing code representing instructions to be executed by a processor includes code to cause the processor to identify a set of anode/cathode pairs. Each anode in the plurality of anode/cathode pairs being only in a first set of electrodes of a first multi-electrode catheter. Each cathode in the set of anode/cathode pairs being only in a second set of electrodes of a second multi-electrode catheter. The first multi-electrode catheter and the second multi-electrode catheter are configured to collectively surround a portion of a heart. The code further includes code to convey a pacing signal to a pacing lead configured to be operatively coupled to the heart, and receive an electrocardiograph signal associated with a function of the heart. The code further includes code to deliver, according to a sequential pattern, a first output signal having a first polarity to each anode selected and a second output signal having a second polarity opposite the first polarity to each cathode selected.
In some embodiments system includes a first flexible catheter including a first set of electrodes and a second flexible catheter including a second set of electrodes. A distal end portion of the first flexible catheter is configured to be coupled to a distal end portion of the second catheter to form a continuous length including the first set of electrodes and the second set of electrodes. The first flexible catheter and the second flexible catheter are configured to deliver a bipolar voltage signal to a target tissue such that a first portion of the bipolar voltage signal having a first polarity is delivered only to the first set of electrodes and a second portion of the bipolar voltage signal having second polarity opposite the first polarity is delivered only to the second set of electrodes.
As used in this specification, the singular forms “a,” “an” and “the” include plural referents unless the context clearly dictates otherwise. Thus, for example, the term “a member” is intended to mean a single member or a combination of members, “a material” is intended to mean one or more materials, “a processor” is intended to mean a single processor or multiple processors; and “memory” is intended to mean one or more memories, or a combination thereof.
As used herein, the terms “about” and “approximately” generally mean plus or minus 10% of the value stated. For example, about 0.5 would include 0.45 and 0.55, about 10 would include 9 to 11, about 1000 would include 900 to 1100.
As shown in
A DC voltage for electroporation can be applied to subsets of electrodes identified as anodes and cathodes respectively on the two catheters on approximately opposite sides of the closed contour defined by the shapes of the catheters 5 and 6 around the pulmonary veins. The DC voltage is applied in brief pulses sufficient to cause irreversible electroporation and can be in the range of 0.5 kV to 10 kV and more preferably in the range 1 kV to 2.5 kV, so that a threshold electric field value of around 200 Volts/cm is effectively achieved in the cardiac tissue to be ablated. In some embodiments, the marked or active electrodes on the two catheters can be automatically identified, or manually identified by suitable marking, on an X-ray or fluoroscopic image obtained at an appropriate angulation that permits identification of the geometric distance between anode and cathode electrodes, or their respective centroids. In one embodiment, the DC voltage generator setting for irreversible electroporation is then automatically identified by the electroporation system based on this distance measure. In an alternate embodiment, the DC voltage value is selected directly by a user from a suitable dial, slider, touch screen, or any other user interface. The DC voltage pulse results in a current flowing between the anode and cathode electrodes on opposite sides of the contour defined by the conjoint shapes of the two catheters, with said current flowing through the cardiac wall tissue and through the intervening blood in the cardiac chamber, with the current entering the cardiac tissue from the anode electrodes and returning back through the cathode electrodes. The forward and return current paths (leads) are respectively inside distinct catheters, since all active electrodes on a given catheter are of like polarity. Areas of cardiac wall tissue where the electric field is sufficiently large for irreversible electroporation are ablated during the DC voltage pulse application.
The catheter shaft is made of a flexible polymeric material such as for example Teflon, Nylon or Pebax. Moreover, the leads 813. 814, 815 and 816 include an insulative covering to ensure that each lead/electrode is electrically isolated from the other leads and electrodes coupled to the catheter shaft 801. When the catheter device is used with the systems and methods described herein, all of the electrodes 803, 804, 805 and 806 of the catheter 801 have the same polarity. Thus, the need for high dielectric strength material separating the leads is not a significant constraint. Accordingly, the insulative material covering each lead can be minimized, and the catheter can be relatively small in diameter. In this manner, the catheter device can have a high degree of flexibility to facilitate the method of surrounding the pulmonary veins as described herein. In some embodiments, for example, the catheter device can have a size in the range of approximately 9 French (3 mm), 8 French (2.67 mm) or even 6 French (2 mm). In some embodiments, the electrode leads of the catheter device can have an insulation thickness of less than about 0.05 mm, less than about 0.01 m, or less than about 0.005 mm. In other embodiments, the electrode leads of the catheter can have an insulation thickness of between about 0.03 mm and about 0.06 mm.
Moreover, by maintaining the voltage for each of the electrodes 803, 804, 805 and 806 of the catheter 801 at the same polarity, higher voltage levels can be applied to the electrodes of the catheter with minimal risk of dielectric breakdown. In this manner, the catheter device 801 (and the systems and methods described herein) can enhance the efficacy of irreversible electroporation ablation. For example, in some embodiments, the voltage applied to the electrodes 803, 804, 805 and 806 can be in the range of 0.5 kV to 2.5 kV; 2.5 kV to 5 kV, and up to 10 kV and more preferably in the range 1 kV to 2.5 kV.
As shown in
Additionally, by using two catheters to deliver a bipolar pulse, but maintaining the voltage for each of the electrodes within each catheter at the same polarity, according to the methods described herein, each of the catheters includes fewer electrodes and few leads than if a single catheter were used to surround the heart. The reduction of the number of leads and electrodes also allows for an overall reduction in the size of the catheter, improvement in the flexibility thereof, and the like.
In some embodiments, for example, a system includes a first catheter including a first set of electrodes and a second flexible catheter including a second set of electrodes. Each of the catheters can be, for example, the catheter 801. A distal end portion of the first flexible catheter is configured to be coupled to a distal end portion of the second catheter to form a continuous length including the first set of electrodes and the second set of electrodes. The connection can be via a magnetic coupling device, as shown herein. The first flexible catheter and the second flexible catheter are configured to deliver a bipolar voltage signal to a target tissue such that a first portion of the bipolar voltage signal having a first polarity is delivered only to the first set of electrodes and a second portion of the bipolar voltage signal haying second polarity opposite the first polarity is delivered only to the second set of electrodes.
The illustration in
A schematic diagram of an electroporation system according to an embodiment is shown in
In some embodiments, one or more leads from the controller 21 could also carry pacing signals to drive pacing of the heart through a separate pacing device (not shown). The catheter devices can also send back information such as ECG recordings or data from other sensors back to the controller 21, possibly on separate leads. While the DC voltage generator 23 sends a DC voltage to the controller 21 through leads 27, the voltage generator is driven by control and timing inputs 28 from the controller unit 21.
As shown in
In one embodiment, the ablation controller and signal generator can be mounted on a rolling trolley, and the user can control the device using a touchscreen interface that is in the sterile field. The touchscreen can be for example an LCD touchscreen in a plastic housing mountable to a standard medical rail or post and can be used to select the electrodes for ablation and to ready the device to fire. The interface can for example be covered with a clear sterile plastic drape. The operator can select the number of electrodes involved in an automated sequence. The touch screen graphically shows the catheters that are attached to the controller. In one embodiment the operator can select electrodes from the touchscreen with appropriate graphical buttons. The operator can also select the pacing stimulus protocol (either internally generated or externally triggered) from the interface. Once pacing is enabled, and the ablation sequence is selected, the operator can initiate or verify pacing. Once the operator verifies that the heart is being paced, the ablation sequence can be initiated by holding down a hand-held trigger button that is in the sterile field. The hand-held trigger button can be illuminated red to indicate that the device is “armed” and ready to ablate. The trigger button can be compatible for use in a sterile field and when attached to the controller can be illuminated a different color, for example white. When the device is firing, the trigger button flashes in sequence with the pulse delivery in a specific color such as red. The waveform of each delivered pulse is displayed on the touchscreen interface. A graphic representation of the pre and post impedance between electrodes involved in the sequence can also be shown on the interface, and this data can be exported for file storage.
In one embodiment, an impedance map can be generated based on voltage and current recordings across anode-cathode pairs or sets of electrodes (anodes and cathodes respectively being on distinct catheters), and an appropriate set of electrodes that are best suited for ablation delivery in a given region can be selected based on the impedance map or measurements, either manually by a user or automatically by the system. Such an impedance map can be produced, for example, by the feedback module 905, or any other suitable portion of the electrode controller 900. For example, if the impedance across an anode/cathode combination of electrodes is a relatively low value (for example, less than 25 Ohms), at a given voltage the said combination would result in relatively large currents in the tissue and power dissipation in tissue. In such circumstances, this electrode combination would then be ruled out for ablation due to safety considerations (e.g., via the selection module 912), and alternate electrode combinations would be sought by the user. In a preferred embodiment, a pre-determined range of impedance values, for example 30 Ohms to 300 Ohms, could be used as an allowed impedance range within which it is deemed safe to ablate. Thus, in some embodiments, an electrode controller can automatically determine a subset of electrodes to which voltage pulses should be applied.
The waveforms for the various electrodes can be displayed and recorded on the case monitor and simultaneously outputted to a standard connection for any electrophysiology (EP) data acquisition system. With the high voltages involved with the device, the outputs to the EP data acquisition system needs to be protected from voltage and/or current surges. The waveforms acquired internally can be used to autonomously calculate impedances between each electrode pair. The waveform amplitude, period, duty cycle, and delay can all be modified, for example via a suitable Ethernet connection. Pacing for the heart is controlled by the device and outputted to the pacing leads and a protected pacing circuit output for monitoring by a lab.
While a touchscreen interface is one preferred embodiment, other user interfaces can be used by a user to control the system such as a graphical display on a laptop or monitor display controlled by a standard computer mouse or joystick.
In some cases, the portion of one of the PV isolation catheters with electrodes may be longer than needed to wrap around a given patient's pulmonary veins; in this event, a smaller number of electrodes is sufficient to wrap around the contour of the pulmonary veins. These define the number of “active” electrodes to be used in the ablation process.
In a some embodiments, the system (any of the generators and controllers described herein) can deliver rectangular-wave pulses with a peak maximum voltage of about 5 kV into a load with an impedance in the range of 30 Ohm to 3000 Ohm for a maximum duration of 200 μs, with a 100 μs maximum duration being still more preferred. Pulses can be delivered in a multiplexed and synchronized manner to a multi-electrode catheter inside the body with a duty cycle of up to 50% (for short bursts). The pulses can generally be delivered in bursts, such as for example a sequence of between 2 and 10 pulses interrupted by pauses of between 1 ms and 1000 ms. The multiplexer controller is capable of running an automated sequence to deliver the impulses/impulse trains (from the DC voltage signal/impulse generator) to the tissue target within the body. The controller system is capable of switching between subsets/nodes of electrodes located on the single-use catheters. Further, the controller can measure voltage and current and tabulate impedances in each electrode configuration (for display, planning, and internal diagnostic analysis). It can also generate two channels of cardiac pacing stimulus output, and is capable of synchronizing impulse delivery with the internally generated cardiac pacing and/or an external trigger signal. In one embodiment, it can provide sensing output/connection for access to bio potentials emanating from each electrode connected to the system (with connectivity characteristics being compatible with standard electrophysiological laboratory data acquisition equipment).
In some embodiments, the controller the electrode controller 900) can automatically “recognize” each of the two single-use disposable catheters when it is connected to the controller output (prompting internal diagnostics and user interface configuration options). The controller can have at least two unique output connector ports (e.g., the first output port 940 and the second output port 942) to accommodate up to at least two catheters at once. The controller device can function as long as at least two recognized catheters are attached to it. In some embodiments, the controller can have several sequence configurations that provide the operator with at least some variety of programming options. In one configuration, the controller can switch electrode configurations of a bipolar set of electrodes (cathodes and anodes respectively on distinct catheters) sequentially in a clockwise mariner (for example, starting at a given step, in the next step of the algorithm, the next cathode electrode on one catheter and the next anode electrode on the other catheter are automatically selected, timed to the synchronizing trigger), with the two catheters and their electrodes arranged in a quasi-circumference around the target. Thus in the first sequence, pulse delivery occurs so that the approximate vector of current density changes as the automated sequencing of the controller switches “on” and “off” between different electrodes surrounding the tissue target sequence. The current density vectors generally cross the target tissue but in some configurations the current density could be approximately tangential to the target. In a second sequence configuration, the impulses are delivered to user-selected electrode subsets of catheters that are connected to the device (the vector of current density does not change with each synchronized delivery). The user can also configure the controller to deliver up to 2 channels of pacing stimulus to electrodes connected to the device output. The user can control the application of DC voltage with a single handheld switch. A sterile catheter or catheters can be connected to the voltage output of the generator via a connector cable that can be delivered to the sterile field. In one embodiment, the user activates the device with a touch screen interface (that can be protected with a single-use sterile transparent disposable cover commonly available in the catheter lab setting). The generator can remain in a standby mode until the user is ready to apply pulses at which point the user/assistant can put the generator into a ready mode via the touchscreen interface. Subsequently the user can select the sequence, the active electrodes, and the cardiac pacing parameters.
Once the catheters have been advanced to or around the cardiac target, the user can initiate electrically pacing the heart (using a pacing stimulus generated by the ablation controller or an external source synchronized to the ablation system). The operator verifies that the heart is being paced and uses the hand-held trigger button to apply the synchronized bursts of high voltage pulses. The system can continue delivering the burst pulse train with each cardiac cycle as long as the operator is holding down a suitable “fire” button or switch. During the application of the pulses, the generator output is synchronized with the heart rhythm so that short bursts are delivered at a pre-specified interval from the paced stimulus. When the train of pulses is complete, the pacing continues until the operator discontinues pacing.
The controller and generator can output waveforms that can be selected to generate a sequence of voltage pulses in either monophasic or biphasic forms and with either constant or progressively changing amplitudes.
Yet another example of a waveform or pulse shape that can be generated by the system is illustrated in
The time duration of each irreversible electroporation rectangular voltage pulse could lie in the range from 1 nanosecond to 10 milliseconds, with the range 10 microseconds to 1 millisecond being more preferable and the range 50 microseconds to 300 microseconds being still more preferable. The time interval between successive pulses of a pulse train could be in the range of 10 microseconds to 1 millisecond, with the range 50 microseconds to 300 microseconds being more preferable. The number of pulses applied in a single pulse train (with delays between individual pulses lying in the ranges just mentioned) can range from 1 to 100, with the range 1 to 10 being more preferable. As described in the foregoing, a pulse train can be driven by a user-controlled switch or button, in one embodiment preferably mounted on a hand-held joystick-like device. In one mode of operation a pulse train can be generated for every push of such a control button, while in an alternate mode of operation pulse trains can be generated repeatedly during the refractory periods of a set of successive cardiac cycles, for as long as the user-controlled switch or button is engaged by the user.
In some embodiments, a method includes identifying, via a selection module of an electrode controller, a set of anode/cathode pairs. Each anode selected in the set of anode/cathode pairs is only in a first set of electrodes of a first multi-electrode catheter. Each cathode selected in the plurality of anode/cathode pairs is only in a second set of electrodes of a second multi-electrode catheter. The first multi-electrode catheter and the second multi-electrode catheter are configured to collectively surround a portion of a heart, as described herein. In some embodiments, the identifying can be based on a predetermined schedule of electrodes. In yet other embodiments, the identifying can be performed automatically based on an impedance measurement or map as described herein.
The method further includes conveying a pacing signal to a pacing lead configured to be operatively coupled to the heart, and receiving, at a feedback module of the electrode controller, an electrocardiograph signal associated with a function of the heart.
The method further includes delivering, via a pulse delivery module of the electrode controller, a first output signal having a first polarity to each anode selected. The method further includes delivering, via the pulse delivery module, a second output signal having a second polarity to each cathode selected. The first output signal and the second output signal being delivered according to a sequential pattern.
Some embodiments described herein relate to a computer storage product with a non-transitory computer-readable medium (also can be referred to as a non-transitory processor-readable medium) having instructions or computer code thereon for performing various computer-implemented operations. The computer-readable medium (or processor-readable medium) is non-transitory in the sense that it does not include transitory propagating signals per se (e.g., a propagating electromagnetic wave carrying information on a transmission medium such as space or a cable). The media and computer code (also can be referred to as code) may be those designed and constructed for the specific purpose or purposes. Examples of non-transitory computer-readable media include, but are not limited to: magnetic storage media such as hard disks, floppy disks, and magnetic tape; optical storage media such as Compact Disc/Digital Video Discs (CD/DVDs), Compact Disc-Read Only Memories (CD-ROMs), and holographic devices; magneto-optical storage media such as optical disks; carrier wave signal processing modules; and hardware devices that are specially configured to store and execute program code, such as Application-Specific Integrated Circuits (ASICs), Programmable Logic Devices (PLDs), Read-Only Memory (ROM) and Random-Access Memory (RAM) devices.
Examples of computer code include, but are not limited to, micro-code or micro-instructions, machine instructions, such as produced by a compiler, code used to produce a web service, and files containing higher-level instructions that are executed by a computer using an interpreter. For example, embodiments may be implemented using imperative programming languages (e.g., C, Fortran, etc.), functional programming languages (Haskell, Ertang, etc.), logical programming languages (e.g., Prolog), object-oriented programming languages (e.g., Java, C++, etc.) or other suitable programming languages and/or development tools. Additional examples of computer code include, but are not limited to, control signals, encrypted code, and compressed code.
While various specific examples and embodiments of systems and tools for selective tissue ablation with irreversible electroporation were described in the foregoing for illustrative and exemplary purposes, it should be clear that a wide variety of variations and alternate embodiments could be conceived or constructed by those skilled in the art based on the teachings herein. While specific methods of control and DC voltage application from a generator capable of selective excitation of sets of electrodes were disclosed, persons skilled in the art would recognize that any of a wide variety of other control or user input methods and methods of electrode subset selection etc. can be implemented without departing from the scope of the present invention. Likewise, while the foregoing described a range of specific tools or devices for more effective and selective DC voltage application for irreversible electroporation through ionic fluid irrigation and ultrasonic agitation, including insulating balloon constructions, focal ablation tools, and a basket catheter with a multiplicity of, other device constructions or variations could be implemented by one skilled in the art by employing the principles and teachings disclosed herein without departing from the scope of the present invention, in the treatment of cardiac arrhythmias, intravascular applications, or a variety of other medical applications.
Furthermore, while the present disclosure describes specific embodiments and tools involving irrigation with saline fluids and the use of temperature to selectively ablate tissue by taking advantage of the temperature-dependence of the threshold of irreversible electroporation, it should be clear to one skilled in the art that a variety of methods and devices for steady fluid delivery, or for tissue heating through the delivery of focused kinetic energy or electromagnetic radiation could be implemented utilizing the methods and principles taught herein without departing from the scope of the present invention.
Where schematics and/or embodiments described above indicate certain components arranged in certain orientations or positions, the arrangement of components may be modified. For example, although the controller 900 is shown as optionally including the pacing module 902, in other embodiments, the controller 900 can interface with a separate pacing module. For example, although the controller 900 is shown as optionally including the feedback module 905, in other embodiments, the controller 900 can interface with a separate feedback module. Similarly, where methods and/or events described above indicate certain events and/or procedures occurring in certain order, the ordering of certain events and/or procedures may be modified.
Although various embodiments have been described as having particular features and/or combinations of components, other embodiments are possible having a combination of any features and/or components from any of embodiments as discussed above.
This application is a continuation of U.S. patent application Ser. No. 15/795,075, entitled “METHODS AND APPARATUS FOR MULTI-CATHETER TISSUE ABLATION,” filed Oct. 26, 2017, which is a continuation of U.S. patent application Ser. No. 15/341,523, entitled “METHODS AND APPARATUS FOR MULTI-CATHETER TISSUE ABLATION,” filed Nov. 2, 2016, now abandoned, which is a continuation of PCT Application No. PCT/US2015/031086, entitled “METHODS AND APPARATUS FOR MULTI-CATHETER TISSUE ABLATION,” filed May 15, 2015, which claims priority to U.S. Provisional Application Ser. No. 61/996,855, entitled “Method and Apparatus for Rapid Multi-Catheter Tissue Ablation,” filed May 16, 2014, the entire disclosures of which are incorporated herein by reference.
Number | Name | Date | Kind |
---|---|---|---|
4200104 | Harris | Apr 1980 | A |
4470407 | Hussein | Sep 1984 | A |
4739759 | Rexroth et al. | Apr 1988 | A |
5234004 | Hascoet et al. | Aug 1993 | A |
5242441 | Avitall | Sep 1993 | A |
5257635 | Langberg | Nov 1993 | A |
5281213 | Milder et al. | Jan 1994 | A |
5304214 | Deford et al. | Apr 1994 | A |
5306296 | Wright et al. | Apr 1994 | A |
5334193 | Nardella | Aug 1994 | A |
5341807 | Nardella | Aug 1994 | A |
5342301 | Saab | Aug 1994 | A |
5398683 | Edwards et al. | Mar 1995 | A |
5443463 | Stern et al. | Aug 1995 | A |
5454370 | Avitall | Oct 1995 | A |
5515848 | Corbett et al. | May 1996 | A |
5531685 | Hemmer et al. | Jul 1996 | A |
5545161 | Imran | Aug 1996 | A |
5558091 | Acker et al. | Sep 1996 | A |
5578040 | Smith | Nov 1996 | A |
5617854 | Munsif | Apr 1997 | A |
5624430 | Eton et al. | Apr 1997 | A |
5662108 | Budd et al. | Sep 1997 | A |
5667491 | Pliquett et al. | Sep 1997 | A |
5672170 | Cho et al. | Sep 1997 | A |
5700243 | Narciso, Jr. | Dec 1997 | A |
5702438 | Avitall | Dec 1997 | A |
5706823 | Wodlinger | Jan 1998 | A |
5722400 | Ockuly et al. | Mar 1998 | A |
5722402 | Swanson et al. | Mar 1998 | A |
5749914 | Janssen | May 1998 | A |
5779699 | Lipson | Jul 1998 | A |
5788692 | Campbell et al. | Aug 1998 | A |
5810762 | Hofmann | Sep 1998 | A |
5833710 | Jacobson | Nov 1998 | A |
5836874 | Swanson et al. | Nov 1998 | A |
5836942 | Netherly et al. | Nov 1998 | A |
5836947 | Fleischman et al. | Nov 1998 | A |
5843154 | Osypka | Dec 1998 | A |
5849028 | Chen | Dec 1998 | A |
5863291 | Schaer | Jan 1999 | A |
5868736 | Swanson et al. | Feb 1999 | A |
5871523 | Fleischman et al. | Feb 1999 | A |
5876336 | Swanson et al. | Mar 1999 | A |
5885278 | Fleischman | Mar 1999 | A |
5895404 | Ruiz | Apr 1999 | A |
5899917 | Edwards et al. | May 1999 | A |
5904709 | Arndt et al. | May 1999 | A |
5916158 | Webster, Jr. | Jun 1999 | A |
5916213 | Haissaguerre et al. | Jun 1999 | A |
5921924 | Avitall | Jul 1999 | A |
5928269 | Alt | Jul 1999 | A |
5928270 | Ramsey, III | Jul 1999 | A |
6002955 | Willems et al. | Dec 1999 | A |
6006131 | Cooper et al. | Dec 1999 | A |
6009351 | Flachman | Dec 1999 | A |
6014579 | Pomeranz et al. | Jan 2000 | A |
6029671 | Stevens et al. | Feb 2000 | A |
6033403 | Tu et al. | Mar 2000 | A |
6035238 | Ingle et al. | Mar 2000 | A |
6045550 | Simpson et al. | Apr 2000 | A |
6068653 | LaFontaine | May 2000 | A |
6071274 | Thompson et al. | Jun 2000 | A |
6071281 | Burnside et al. | Jun 2000 | A |
6074389 | Levine et al. | Jun 2000 | A |
6076012 | Swanson et al. | Jun 2000 | A |
6090104 | Webster, Jr. | Jul 2000 | A |
6096036 | Bowe et al. | Aug 2000 | A |
6113595 | Muntermann | Sep 2000 | A |
6119041 | Pomeranz et al. | Sep 2000 | A |
6120500 | Bednarek et al. | Sep 2000 | A |
6146381 | Bowe et al. | Nov 2000 | A |
6164283 | Lesh | Dec 2000 | A |
6165172 | Farley | Dec 2000 | A |
6167291 | Barajas et al. | Dec 2000 | A |
6171305 | Sherman | Jan 2001 | B1 |
6216034 | Hofmann et al. | Apr 2001 | B1 |
6219582 | Hofstad et al. | Apr 2001 | B1 |
6223085 | Dann et al. | Apr 2001 | B1 |
6231518 | Grabek et al. | May 2001 | B1 |
6245064 | Lesh et al. | Jun 2001 | B1 |
6251107 | Schaer | Jun 2001 | B1 |
6251128 | Knopp et al. | Jun 2001 | B1 |
6270476 | Santoianni et al. | Aug 2001 | B1 |
6272384 | Simon et al. | Aug 2001 | B1 |
6287306 | Kroll et al. | Sep 2001 | B1 |
6314963 | Vaska et al. | Nov 2001 | B1 |
6322559 | Daulton et al. | Nov 2001 | B1 |
6350263 | Wetzig et al. | Feb 2002 | B1 |
6370412 | Armoundas et al. | Apr 2002 | B1 |
6391024 | Sun et al. | May 2002 | B1 |
6447505 | McGovern et al. | Sep 2002 | B2 |
6464699 | Swanson | Oct 2002 | B1 |
6470211 | Ideker et al. | Oct 2002 | B1 |
6502576 | Lesh | Jan 2003 | B1 |
6503247 | Swartz et al. | Jan 2003 | B2 |
6517534 | McGovern et al. | Feb 2003 | B1 |
6527724 | Fenici | Mar 2003 | B1 |
6527767 | Wang et al. | Mar 2003 | B2 |
6592581 | Bowe | Jul 2003 | B2 |
6595991 | Toellner et al. | Jul 2003 | B2 |
6607520 | Keane | Aug 2003 | B2 |
6623480 | Kuo et al. | Sep 2003 | B1 |
6638278 | Falwell et al. | Oct 2003 | B2 |
6666863 | Wentzel et al. | Dec 2003 | B2 |
6669693 | Friedman | Dec 2003 | B2 |
6702811 | Stewart et al. | Mar 2004 | B2 |
6719756 | Muntermann | Apr 2004 | B1 |
6723092 | Brown et al. | Apr 2004 | B2 |
6728563 | Rashidi | Apr 2004 | B2 |
6743225 | Sanchez et al. | Jun 2004 | B2 |
6743226 | Cosman et al. | Jun 2004 | B2 |
6743239 | Kuehn et al. | Jun 2004 | B1 |
6764486 | Natale | Jul 2004 | B2 |
6780181 | Kroll et al. | Aug 2004 | B2 |
6805128 | Pless et al. | Oct 2004 | B1 |
6807447 | Griffin, III | Oct 2004 | B2 |
6892091 | Ben-Haim et al. | May 2005 | B1 |
6893438 | Hall et al. | May 2005 | B2 |
6926714 | Sra | Aug 2005 | B1 |
6955173 | Lesh | Oct 2005 | B2 |
6960206 | Keane | Nov 2005 | B2 |
6960207 | Vanney et al. | Nov 2005 | B2 |
6972016 | Hill et al. | Dec 2005 | B2 |
6973339 | Govari | Dec 2005 | B2 |
6979331 | Hintringer et al. | Dec 2005 | B2 |
6984232 | Vanney et al. | Jan 2006 | B2 |
6985776 | Kane et al. | Jan 2006 | B2 |
7001383 | Keidar | Feb 2006 | B2 |
7041095 | Wang et al. | May 2006 | B2 |
7113831 | Hooven | Sep 2006 | B2 |
7171263 | Darvish et al. | Jan 2007 | B2 |
7182725 | Bonan et al. | Feb 2007 | B2 |
7195628 | Falkenberg | Mar 2007 | B2 |
7207988 | Leckrone et al. | Apr 2007 | B2 |
7207989 | Pike et al. | Apr 2007 | B2 |
7229402 | Diaz et al. | Jun 2007 | B2 |
7229437 | Johnson et al. | Jun 2007 | B2 |
7250049 | Roop et al. | Jul 2007 | B2 |
7282057 | Surti et al. | Oct 2007 | B2 |
7285116 | De et al. | Oct 2007 | B2 |
7285119 | Stewart et al. | Oct 2007 | B2 |
7326208 | Vanney et al. | Feb 2008 | B2 |
7346379 | Eng et al. | Mar 2008 | B2 |
7367974 | Haemmerich et al. | May 2008 | B2 |
7374567 | Heuser | May 2008 | B2 |
7387629 | Vanney et al. | Jun 2008 | B2 |
7387630 | Mest | Jun 2008 | B2 |
7387636 | Cohn et al. | Jun 2008 | B2 |
7416552 | Paul et al. | Aug 2008 | B2 |
7419477 | Simpson et al. | Sep 2008 | B2 |
7419489 | Vanney et al. | Sep 2008 | B2 |
7422591 | Phan | Sep 2008 | B2 |
7429261 | Kunis et al. | Sep 2008 | B2 |
7435248 | Taimisto et al. | Oct 2008 | B2 |
7513896 | Orszulak | Apr 2009 | B2 |
7527625 | Knight et al. | May 2009 | B2 |
7578816 | Boveja et al. | Aug 2009 | B2 |
7588567 | Boveja et al. | Sep 2009 | B2 |
7623899 | Worley et al. | Nov 2009 | B2 |
7678108 | Chrisitian et al. | Mar 2010 | B2 |
7681579 | Schwartz | Mar 2010 | B2 |
7771421 | Stewart et al. | Aug 2010 | B2 |
7805182 | Weese et al. | Sep 2010 | B2 |
7850642 | Moll et al. | Dec 2010 | B2 |
7850685 | Kunis et al. | Dec 2010 | B2 |
7857808 | Oral et al. | Dec 2010 | B2 |
7857809 | Drysen | Dec 2010 | B2 |
7869865 | Govari et al. | Jan 2011 | B2 |
7896873 | Hiller et al. | Mar 2011 | B2 |
7917211 | Zacouto | Mar 2011 | B2 |
7918819 | Karmarkar et al. | Apr 2011 | B2 |
7918850 | Govari et al. | Apr 2011 | B2 |
7922714 | Stevens-Wright | Apr 2011 | B2 |
7955827 | Rubinsky et al. | Jun 2011 | B2 |
8048067 | Davalos et al. | Nov 2011 | B2 |
8048072 | Verin et al. | Nov 2011 | B2 |
8100895 | Panos et al. | Jan 2012 | B2 |
8100900 | Prinz et al. | Jan 2012 | B2 |
8108069 | Stahler et al. | Jan 2012 | B2 |
8133220 | Lee et al. | Mar 2012 | B2 |
8137342 | Crossman | Mar 2012 | B2 |
8145289 | Calabro′ et al. | Mar 2012 | B2 |
8147486 | Honour et al. | Apr 2012 | B2 |
8160690 | Wilfley et al. | Apr 2012 | B2 |
8175680 | Panescu | May 2012 | B2 |
8182477 | Orszulak et al. | May 2012 | B2 |
8206384 | Falwell et al. | Jun 2012 | B2 |
8206385 | Stangenes et al. | Jun 2012 | B2 |
8216221 | Ibrahim et al. | Jul 2012 | B2 |
8221411 | Francischelli et al. | Jul 2012 | B2 |
8226648 | Paul et al. | Jul 2012 | B2 |
8228065 | Wirtz et al. | Jul 2012 | B2 |
8235986 | Kulesa et al. | Aug 2012 | B2 |
8235988 | Davis et al. | Aug 2012 | B2 |
8251986 | Chornenky et al. | Aug 2012 | B2 |
8282631 | Davalos et al. | Oct 2012 | B2 |
8287532 | Carroll et al. | Oct 2012 | B2 |
8414508 | Thapliyal et al. | Apr 2013 | B2 |
8430875 | Ibrahim et al. | Apr 2013 | B2 |
8433394 | Harlev et al. | Apr 2013 | B2 |
8449535 | Deno et al. | May 2013 | B2 |
8454594 | Demarais et al. | Jun 2013 | B2 |
8463368 | Harlev et al. | Jun 2013 | B2 |
8475450 | Govari et al. | Jul 2013 | B2 |
8486063 | Werneth et al. | Jul 2013 | B2 |
8500733 | Watson | Aug 2013 | B2 |
8535304 | Sklar et al. | Sep 2013 | B2 |
8538501 | Venkatachalam et al. | Sep 2013 | B2 |
8562588 | Hobbs et al. | Oct 2013 | B2 |
8568406 | Harlev et al. | Oct 2013 | B2 |
8571635 | McGee | Oct 2013 | B2 |
8571647 | Harlev et al. | Oct 2013 | B2 |
8585695 | Shih | Nov 2013 | B2 |
8588885 | Hall et al. | Nov 2013 | B2 |
8597288 | Christian | Dec 2013 | B2 |
8608735 | Govari et al. | Dec 2013 | B2 |
8628522 | Ibrahim et al. | Jan 2014 | B2 |
8632534 | Pearson et al. | Jan 2014 | B2 |
8647338 | Chornenky et al. | Feb 2014 | B2 |
8708952 | Cohen et al. | Apr 2014 | B2 |
8734442 | Cao et al. | May 2014 | B2 |
8771267 | Kunis et al. | Jul 2014 | B2 |
8795310 | Fung et al. | Aug 2014 | B2 |
8808273 | Caples et al. | Aug 2014 | B2 |
8808281 | Emmons et al. | Aug 2014 | B2 |
8834461 | Werneth et al. | Sep 2014 | B2 |
8834464 | Stewart et al. | Sep 2014 | B2 |
8868169 | Narayan et al. | Oct 2014 | B2 |
8876817 | Avitall et al. | Nov 2014 | B2 |
8880195 | Azure | Nov 2014 | B2 |
8886309 | Luther et al. | Nov 2014 | B2 |
8903488 | Callas et al. | Dec 2014 | B2 |
8920411 | Gelbart et al. | Dec 2014 | B2 |
8926589 | Govari | Jan 2015 | B2 |
8932287 | Gelbart et al. | Jan 2015 | B2 |
8945117 | Bencini | Feb 2015 | B2 |
8979841 | Kunis et al. | Mar 2015 | B2 |
8986278 | Fung et al. | Mar 2015 | B2 |
9002442 | Harley et al. | Apr 2015 | B2 |
9005189 | Davalos et al. | Apr 2015 | B2 |
9005194 | Oral et al. | Apr 2015 | B2 |
9011425 | Fischer et al. | Apr 2015 | B2 |
9044245 | Condie et al. | Jun 2015 | B2 |
9055959 | Vaska et al. | Jun 2015 | B2 |
9072518 | Swanson | Jul 2015 | B2 |
9078667 | Besser et al. | Jul 2015 | B2 |
9101374 | Hoch et al. | Aug 2015 | B1 |
9119533 | Ghaffari | Sep 2015 | B2 |
9119634 | Gelbart et al. | Sep 2015 | B2 |
9131897 | Harada et al. | Sep 2015 | B2 |
9155590 | Mathur | Oct 2015 | B2 |
9162037 | Belson et al. | Oct 2015 | B2 |
9179972 | Olson | Nov 2015 | B2 |
9186481 | Avitall et al. | Nov 2015 | B2 |
9192769 | Donofrio et al. | Nov 2015 | B2 |
9211405 | Mahapatra et al. | Dec 2015 | B2 |
9216055 | Spence et al. | Dec 2015 | B2 |
9233248 | Luther et al. | Jan 2016 | B2 |
9237926 | Nollert et al. | Jan 2016 | B2 |
9262252 | Kirkpatrick et al. | Feb 2016 | B2 |
9277957 | Long et al. | Mar 2016 | B2 |
9282910 | Narayan et al. | Mar 2016 | B2 |
9289258 | Cohen | Mar 2016 | B2 |
9289606 | Paul et al. | Mar 2016 | B2 |
9295516 | Pearson et al. | Mar 2016 | B2 |
9301801 | Scheib | Apr 2016 | B2 |
9375268 | Long | Jun 2016 | B2 |
9414881 | Callas et al. | Aug 2016 | B2 |
9468495 | Kunis et al. | Oct 2016 | B2 |
9474486 | Eliason et al. | Oct 2016 | B2 |
9474574 | Ibrahim et al. | Oct 2016 | B2 |
9480525 | Lopes et al. | Nov 2016 | B2 |
9486272 | Bonyak et al. | Nov 2016 | B2 |
9486273 | Lopes et al. | Nov 2016 | B2 |
9492227 | Lopes et al. | Nov 2016 | B2 |
9492228 | Lopes et al. | Nov 2016 | B2 |
9517103 | Panescu et al. | Dec 2016 | B2 |
9526573 | Lopes et al. | Dec 2016 | B2 |
9532831 | Reinders et al. | Jan 2017 | B2 |
9539010 | Gagner et al. | Jan 2017 | B2 |
9554848 | Stewart et al. | Jan 2017 | B2 |
9554851 | Sklar et al. | Jan 2017 | B2 |
9700368 | Callas et al. | Jul 2017 | B2 |
9724170 | Mickelsen | Aug 2017 | B2 |
9757193 | Zarins et al. | Sep 2017 | B2 |
9782099 | Williams et al. | Oct 2017 | B2 |
9795442 | Salahieh et al. | Oct 2017 | B2 |
9861802 | Mickelsen | Jan 2018 | B2 |
9913685 | Clark et al. | Mar 2018 | B2 |
9931487 | Quinn et al. | Apr 2018 | B2 |
9987081 | Bowers et al. | Jun 2018 | B1 |
9999465 | Long et al. | Jun 2018 | B2 |
10016232 | Bowers et al. | Jul 2018 | B1 |
10117707 | Garcia et al. | Nov 2018 | B2 |
10130423 | Viswanathan et al. | Nov 2018 | B1 |
10172673 | Viswanathan et al. | Jan 2019 | B2 |
10292755 | Arena et al. | May 2019 | B2 |
10322286 | Viswanathan et al. | Jun 2019 | B2 |
10433906 | Mickelsen | Oct 2019 | B2 |
10433908 | Viswanathan et al. | Oct 2019 | B2 |
10448989 | Arena et al. | Oct 2019 | B2 |
10507302 | Leeflang et al. | Dec 2019 | B2 |
10512505 | Viswanathan | Dec 2019 | B2 |
10512779 | Viswanathan et al. | Dec 2019 | B2 |
10517672 | Long | Dec 2019 | B2 |
20010000791 | Suorsa et al. | May 2001 | A1 |
20010007070 | Stewart et al. | Jul 2001 | A1 |
20010044624 | Seraj et al. | Nov 2001 | A1 |
20020052602 | Wang et al. | May 2002 | A1 |
20020077627 | Johnson et al. | Jun 2002 | A1 |
20020087169 | Brock et al. | Jul 2002 | A1 |
20020091384 | Hooven et al. | Jul 2002 | A1 |
20020095176 | Prestel | Jul 2002 | A1 |
20020111618 | Stewart et al. | Aug 2002 | A1 |
20020156526 | Hlavka et al. | Oct 2002 | A1 |
20020161323 | Miller et al. | Oct 2002 | A1 |
20020169445 | Jain et al. | Nov 2002 | A1 |
20020177765 | Bowe et al. | Nov 2002 | A1 |
20020183638 | Swanson | Dec 2002 | A1 |
20030014098 | Quijano et al. | Jan 2003 | A1 |
20030018374 | Paulos | Jan 2003 | A1 |
20030023287 | Edwards et al. | Jan 2003 | A1 |
20030028189 | Woloszko et al. | Feb 2003 | A1 |
20030050637 | Maguire et al. | Mar 2003 | A1 |
20030114849 | Ryan | Jun 2003 | A1 |
20030125729 | Hooven et al. | Jul 2003 | A1 |
20030130598 | Manning et al. | Jul 2003 | A1 |
20030130711 | Pearson et al. | Jul 2003 | A1 |
20030204161 | Ferek-Petric | Oct 2003 | A1 |
20030229379 | Ramsey | Dec 2003 | A1 |
20040039382 | Kroll et al. | Feb 2004 | A1 |
20040049181 | Stewart et al. | Mar 2004 | A1 |
20040049182 | Koblish et al. | Mar 2004 | A1 |
20040082859 | Schaer | Apr 2004 | A1 |
20040082948 | Stewart et al. | Apr 2004 | A1 |
20040087939 | Eggers et al. | May 2004 | A1 |
20040111087 | Stern et al. | Jun 2004 | A1 |
20040199157 | Palanker et al. | Oct 2004 | A1 |
20040215139 | Cohen | Oct 2004 | A1 |
20040231683 | Eng et al. | Nov 2004 | A1 |
20040236360 | Cohn et al. | Nov 2004 | A1 |
20040254607 | Wittenberger et al. | Dec 2004 | A1 |
20040267337 | Hayzelden | Dec 2004 | A1 |
20050033282 | Hooven | Feb 2005 | A1 |
20050187545 | Hooven et al. | Aug 2005 | A1 |
20050222632 | Obino | Oct 2005 | A1 |
20050251130 | Boveja et al. | Nov 2005 | A1 |
20050261672 | Deem et al. | Nov 2005 | A1 |
20060009755 | Sra | Jan 2006 | A1 |
20060009759 | Chrisitian et al. | Jan 2006 | A1 |
20060015095 | Desinger | Jan 2006 | A1 |
20060015165 | Bertolero et al. | Jan 2006 | A1 |
20060024359 | Walker et al. | Feb 2006 | A1 |
20060058781 | Long | Mar 2006 | A1 |
20060111702 | Oral et al. | May 2006 | A1 |
20060142801 | Demarais et al. | Jun 2006 | A1 |
20060167448 | Kozel | Jul 2006 | A1 |
20060217703 | Chornenky et al. | Sep 2006 | A1 |
20060241734 | Marshall et al. | Oct 2006 | A1 |
20060247746 | Danek | Nov 2006 | A1 |
20060264752 | Rubinsky et al. | Nov 2006 | A1 |
20060270900 | Chin et al. | Nov 2006 | A1 |
20060287648 | Schwartz | Dec 2006 | A1 |
20060293730 | Rubinsky et al. | Dec 2006 | A1 |
20060293731 | Rubinsky et al. | Dec 2006 | A1 |
20070005053 | Dando | Jan 2007 | A1 |
20070021744 | Creighton | Jan 2007 | A1 |
20070060989 | Deem et al. | Mar 2007 | A1 |
20070066972 | Ormsby et al. | Mar 2007 | A1 |
20070129721 | Phan et al. | Jun 2007 | A1 |
20070129760 | Demarais et al. | Jun 2007 | A1 |
20070156135 | Rubinsky et al. | Jul 2007 | A1 |
20070167740 | Grunewald et al. | Jul 2007 | A1 |
20070167940 | Stevens-Wright | Jul 2007 | A1 |
20070173878 | Heuser | Jul 2007 | A1 |
20070208329 | Ward et al. | Sep 2007 | A1 |
20070225589 | Viswanathan | Sep 2007 | A1 |
20070249923 | Keenan | Oct 2007 | A1 |
20070260223 | Scheibe et al. | Nov 2007 | A1 |
20070270792 | Hennemann et al. | Nov 2007 | A1 |
20080009855 | Hamou | Jan 2008 | A1 |
20080033426 | Machell | Feb 2008 | A1 |
20080065061 | Viswanathan | Mar 2008 | A1 |
20080086120 | Mirza et al. | Apr 2008 | A1 |
20080091195 | Sliwa et al. | Apr 2008 | A1 |
20080103545 | Bolea et al. | May 2008 | A1 |
20080132885 | Rubinsky et al. | Jun 2008 | A1 |
20080161789 | Thao et al. | Jul 2008 | A1 |
20080172048 | Martin et al. | Jul 2008 | A1 |
20080200913 | Viswanathan | Aug 2008 | A1 |
20080208118 | Goldman | Aug 2008 | A1 |
20080243214 | Koblish | Oct 2008 | A1 |
20080281322 | Sherman et al. | Nov 2008 | A1 |
20080300574 | Belson et al. | Dec 2008 | A1 |
20080300588 | Groth et al. | Dec 2008 | A1 |
20080319436 | Daniel et al. | Dec 2008 | A1 |
20090024084 | Khosla et al. | Jan 2009 | A1 |
20090048591 | Ibrahim et al. | Feb 2009 | A1 |
20090062788 | Long et al. | Mar 2009 | A1 |
20090076500 | Azure | Mar 2009 | A1 |
20090105654 | Kurth et al. | Apr 2009 | A1 |
20090138009 | Viswanathan et al. | May 2009 | A1 |
20090149917 | Whitehurst et al. | Jun 2009 | A1 |
20090163905 | Winkler et al. | Jun 2009 | A1 |
20090228003 | Sinelnikov | Sep 2009 | A1 |
20090240248 | Deford et al. | Sep 2009 | A1 |
20090275827 | Aiken et al. | Nov 2009 | A1 |
20090281477 | Mikus et al. | Nov 2009 | A1 |
20090306651 | Schneider | Dec 2009 | A1 |
20100004623 | Hamilton et al. | Jan 2010 | A1 |
20100010486 | Mehta | Jan 2010 | A1 |
20100023004 | Francischelli et al. | Jan 2010 | A1 |
20100100093 | Azure | Apr 2010 | A1 |
20100137861 | Soroff et al. | Jun 2010 | A1 |
20100185140 | Kassab et al. | Jul 2010 | A1 |
20100185186 | Longoria | Jul 2010 | A1 |
20100191112 | Demarais et al. | Jul 2010 | A1 |
20100191232 | Boveda | Jul 2010 | A1 |
20100241185 | Mahapatra et al. | Sep 2010 | A1 |
20100261994 | Davalos et al. | Oct 2010 | A1 |
20100274238 | Klimovitch | Oct 2010 | A1 |
20100280513 | Juergen et al. | Nov 2010 | A1 |
20100280539 | Miyoshi et al. | Nov 2010 | A1 |
20100292687 | Kauphusman et al. | Nov 2010 | A1 |
20100312096 | Guttman et al. | Dec 2010 | A1 |
20100312300 | Ryu et al. | Dec 2010 | A1 |
20110028962 | Werneth et al. | Feb 2011 | A1 |
20110028964 | Edwards | Feb 2011 | A1 |
20110040199 | Hopenfeld | Feb 2011 | A1 |
20110098694 | Long | Apr 2011 | A1 |
20110106221 | Neal et al. | May 2011 | A1 |
20110130708 | Perry et al. | Jun 2011 | A1 |
20110144524 | Fish et al. | Jun 2011 | A1 |
20110144633 | Govari | Jun 2011 | A1 |
20110160785 | Mori et al. | Jun 2011 | A1 |
20110190659 | Long et al. | Aug 2011 | A1 |
20110190727 | Edmunds et al. | Aug 2011 | A1 |
20110213231 | Hall et al. | Sep 2011 | A1 |
20110276047 | Sklar et al. | Nov 2011 | A1 |
20110276075 | Fung et al. | Nov 2011 | A1 |
20110288544 | Verin et al. | Nov 2011 | A1 |
20110288547 | Morgan et al. | Nov 2011 | A1 |
20110313417 | De et al. | Dec 2011 | A1 |
20120029512 | Willard et al. | Feb 2012 | A1 |
20120046570 | Villegas et al. | Feb 2012 | A1 |
20120053581 | Wittkampf et al. | Mar 2012 | A1 |
20120059255 | Paul et al. | Mar 2012 | A1 |
20120071872 | Rubinsky et al. | Mar 2012 | A1 |
20120078320 | Schotzko et al. | Mar 2012 | A1 |
20120078343 | Fish | Mar 2012 | A1 |
20120089089 | Swain et al. | Apr 2012 | A1 |
20120095459 | Callas et al. | Apr 2012 | A1 |
20120101413 | Beetel et al. | Apr 2012 | A1 |
20120158021 | Morrill | Jun 2012 | A1 |
20120165667 | Altmann et al. | Jun 2012 | A1 |
20120172859 | Condie et al. | Jul 2012 | A1 |
20120172867 | Ryu et al. | Jul 2012 | A1 |
20120197100 | Razavi et al. | Aug 2012 | A1 |
20120209260 | Lambert et al. | Aug 2012 | A1 |
20120220998 | Long et al. | Aug 2012 | A1 |
20120265198 | Crow et al. | Oct 2012 | A1 |
20120283582 | Mahapatra et al. | Nov 2012 | A1 |
20120303019 | Zhao et al. | Nov 2012 | A1 |
20120310052 | Mahapatra et al. | Dec 2012 | A1 |
20120310230 | Willis | Dec 2012 | A1 |
20120310237 | Swanson | Dec 2012 | A1 |
20120316557 | Sartor et al. | Dec 2012 | A1 |
20130030430 | Stewart et al. | Jan 2013 | A1 |
20130060247 | Sklar et al. | Mar 2013 | A1 |
20130060248 | Sklar et al. | Mar 2013 | A1 |
20130079768 | De et al. | Mar 2013 | A1 |
20130090651 | Smith | Apr 2013 | A1 |
20130096655 | Moffitt et al. | Apr 2013 | A1 |
20130103027 | Sklar et al. | Apr 2013 | A1 |
20130103064 | Arenson et al. | Apr 2013 | A1 |
20130131662 | Wittkampf | May 2013 | A1 |
20130158538 | Govari | Jun 2013 | A1 |
20130158621 | Ding et al. | Jun 2013 | A1 |
20130172715 | Just et al. | Jul 2013 | A1 |
20130172864 | Ibrahim et al. | Jul 2013 | A1 |
20130172875 | Govari et al. | Jul 2013 | A1 |
20130184702 | Neal et al. | Jul 2013 | A1 |
20130218157 | Callas et al. | Aug 2013 | A1 |
20130226174 | Ibrahim et al. | Aug 2013 | A1 |
20130237984 | Sklar | Sep 2013 | A1 |
20130253415 | Sano et al. | Sep 2013 | A1 |
20130296679 | Condie et al. | Nov 2013 | A1 |
20130310829 | Cohen | Nov 2013 | A1 |
20130317385 | Sklar et al. | Nov 2013 | A1 |
20130331831 | Werneth et al. | Dec 2013 | A1 |
20130338467 | Grasse et al. | Dec 2013 | A1 |
20140005664 | Govari et al. | Jan 2014 | A1 |
20140024911 | Harlev et al. | Jan 2014 | A1 |
20140039288 | Shih | Feb 2014 | A1 |
20140051993 | McGee | Feb 2014 | A1 |
20140052118 | Laske et al. | Feb 2014 | A1 |
20140052126 | Long et al. | Feb 2014 | A1 |
20140052216 | Long et al. | Feb 2014 | A1 |
20140058377 | Deem et al. | Feb 2014 | A1 |
20140081113 | Cohen et al. | Mar 2014 | A1 |
20140100563 | Govari et al. | Apr 2014 | A1 |
20140107644 | Falwell et al. | Apr 2014 | A1 |
20140142408 | De et al. | May 2014 | A1 |
20140148804 | Ward et al. | May 2014 | A1 |
20140163480 | Govari et al. | Jun 2014 | A1 |
20140163546 | Govari et al. | Jun 2014 | A1 |
20140171942 | Werneth et al. | Jun 2014 | A1 |
20140180035 | Anderson | Jun 2014 | A1 |
20140187916 | Clark et al. | Jul 2014 | A1 |
20140194716 | Diep et al. | Jul 2014 | A1 |
20140194867 | Fish et al. | Jul 2014 | A1 |
20140200567 | Cox et al. | Jul 2014 | A1 |
20140235986 | Harlev et al. | Aug 2014 | A1 |
20140235988 | Ghosh | Aug 2014 | A1 |
20140235989 | Wodlinger et al. | Aug 2014 | A1 |
20140243851 | Cohen et al. | Aug 2014 | A1 |
20140276712 | Mallin et al. | Sep 2014 | A1 |
20140276760 | Bonyak et al. | Sep 2014 | A1 |
20140276782 | Paskar | Sep 2014 | A1 |
20140276791 | Ku et al. | Sep 2014 | A1 |
20140288556 | Ibrahim et al. | Sep 2014 | A1 |
20140303721 | Fung et al. | Oct 2014 | A1 |
20140343549 | Spear et al. | Nov 2014 | A1 |
20140364845 | Rashidi | Dec 2014 | A1 |
20140371613 | Narayan et al. | Dec 2014 | A1 |
20150005767 | Werneth et al. | Jan 2015 | A1 |
20150011995 | Avitall et al. | Jan 2015 | A1 |
20150066108 | Shi et al. | Mar 2015 | A1 |
20150119674 | Fischell et al. | Apr 2015 | A1 |
20150126840 | Thakur et al. | May 2015 | A1 |
20150133914 | Koblish | May 2015 | A1 |
20150138977 | Dacosta | May 2015 | A1 |
20150141978 | Subramaniam et al. | May 2015 | A1 |
20150142041 | Kendale et al. | May 2015 | A1 |
20150148796 | Bencini | May 2015 | A1 |
20150150472 | Harlev et al. | Jun 2015 | A1 |
20150157402 | Kunis et al. | Jun 2015 | A1 |
20150157412 | Wallace et al. | Jun 2015 | A1 |
20150164584 | Davalos et al. | Jun 2015 | A1 |
20150173824 | Davalos et al. | Jun 2015 | A1 |
20150173828 | Avitall | Jun 2015 | A1 |
20150174404 | Rousso et al. | Jun 2015 | A1 |
20150182740 | Mickelsen | Jul 2015 | A1 |
20150196217 | Harlev et al. | Jul 2015 | A1 |
20150223726 | Harlev et al. | Aug 2015 | A1 |
20150230699 | Berul et al. | Aug 2015 | A1 |
20150258344 | Tandri et al. | Sep 2015 | A1 |
20150265342 | Long et al. | Sep 2015 | A1 |
20150265344 | Aktas et al. | Sep 2015 | A1 |
20150272656 | Chen | Oct 2015 | A1 |
20150272664 | Cohen | Oct 2015 | A9 |
20150272667 | Govari et al. | Oct 2015 | A1 |
20150282729 | Harlev et al. | Oct 2015 | A1 |
20150289923 | Davalos et al. | Oct 2015 | A1 |
20150304879 | Dacosta | Oct 2015 | A1 |
20150320481 | Cosman et al. | Nov 2015 | A1 |
20150321021 | Tandri et al. | Nov 2015 | A1 |
20150327944 | Neal et al. | Nov 2015 | A1 |
20150342532 | Basu et al. | Dec 2015 | A1 |
20150343212 | Rousso et al. | Dec 2015 | A1 |
20150351836 | Prutchi | Dec 2015 | A1 |
20150359583 | Swanson | Dec 2015 | A1 |
20160000500 | Salahieh et al. | Jan 2016 | A1 |
20160008061 | Fung et al. | Jan 2016 | A1 |
20160008065 | Gliner et al. | Jan 2016 | A1 |
20160029960 | Toth et al. | Feb 2016 | A1 |
20160038772 | Thapliyal et al. | Feb 2016 | A1 |
20160051204 | Harlev et al. | Feb 2016 | A1 |
20160051324 | Stewart et al. | Feb 2016 | A1 |
20160058493 | Neal et al. | Mar 2016 | A1 |
20160058506 | Spence et al. | Mar 2016 | A1 |
20160066993 | Avitall et al. | Mar 2016 | A1 |
20160074679 | Thapliyal et al. | Mar 2016 | A1 |
20160095531 | Narayan et al. | Apr 2016 | A1 |
20160095642 | Deno et al. | Apr 2016 | A1 |
20160095653 | Lambert et al. | Apr 2016 | A1 |
20160100797 | Mahapatra et al. | Apr 2016 | A1 |
20160100884 | Fay et al. | Apr 2016 | A1 |
20160106498 | Highsmith et al. | Apr 2016 | A1 |
20160106500 | Olson | Apr 2016 | A1 |
20160113709 | Maor | Apr 2016 | A1 |
20160113712 | Cheung et al. | Apr 2016 | A1 |
20160120564 | Kirkpatrick et al. | May 2016 | A1 |
20160128770 | Afonso et al. | May 2016 | A1 |
20160166167 | Narayan et al. | Jun 2016 | A1 |
20160166310 | Stewart et al. | Jun 2016 | A1 |
20160166311 | Long et al. | Jun 2016 | A1 |
20160174865 | Stewart et al. | Jun 2016 | A1 |
20160183877 | Williams et al. | Jun 2016 | A1 |
20160184003 | Srimathveeravalli et al. | Jun 2016 | A1 |
20160184004 | Hull et al. | Jun 2016 | A1 |
20160213282 | Leo et al. | Jul 2016 | A1 |
20160220307 | Miller et al. | Aug 2016 | A1 |
20160235470 | Callas et al. | Aug 2016 | A1 |
20160287314 | Arena et al. | Oct 2016 | A1 |
20160310211 | Long | Oct 2016 | A1 |
20160324564 | Gerlach et al. | Nov 2016 | A1 |
20160324573 | Mickelson et al. | Nov 2016 | A1 |
20160331441 | Konings | Nov 2016 | A1 |
20160331459 | Townley et al. | Nov 2016 | A1 |
20160354142 | Pearson et al. | Dec 2016 | A1 |
20160361109 | Weaver et al. | Dec 2016 | A1 |
20170001016 | De Ridder | Jan 2017 | A1 |
20170035499 | Stewart et al. | Feb 2017 | A1 |
20170042449 | Deno et al. | Feb 2017 | A1 |
20170042615 | Salahieh et al. | Feb 2017 | A1 |
20170056648 | Syed et al. | Mar 2017 | A1 |
20170065330 | Mickelsen et al. | Mar 2017 | A1 |
20170065339 | Mickelsen | Mar 2017 | A1 |
20170065340 | Long | Mar 2017 | A1 |
20170065343 | Mickelsen | Mar 2017 | A1 |
20170071543 | Basu et al. | Mar 2017 | A1 |
20170095291 | Harrington et al. | Apr 2017 | A1 |
20170105793 | Cao et al. | Apr 2017 | A1 |
20170120048 | He et al. | May 2017 | A1 |
20170146584 | Daw et al. | May 2017 | A1 |
20170151029 | Mickelsen | Jun 2017 | A1 |
20170172654 | Wittkampf et al. | Jun 2017 | A1 |
20170181795 | Debruyne | Jun 2017 | A1 |
20170189097 | Viswanathan et al. | Jul 2017 | A1 |
20170215953 | Long et al. | Aug 2017 | A1 |
20170245928 | Xiao et al. | Aug 2017 | A1 |
20170246455 | Athos et al. | Aug 2017 | A1 |
20170312024 | Harlev et al. | Nov 2017 | A1 |
20170312025 | Harlev et al. | Nov 2017 | A1 |
20170312027 | Harlev et al. | Nov 2017 | A1 |
20180001056 | Leeflang et al. | Jan 2018 | A1 |
20180042674 | Mickelsen | Feb 2018 | A1 |
20180042675 | Long | Feb 2018 | A1 |
20180043153 | Viswanathan et al. | Feb 2018 | A1 |
20180064488 | Long et al. | Mar 2018 | A1 |
20180085160 | Viswanathan et al. | Mar 2018 | A1 |
20180093088 | Mickelsen | Apr 2018 | A1 |
20180133460 | Townley et al. | May 2018 | A1 |
20180168511 | Hall et al. | Jun 2018 | A1 |
20180184982 | Basu et al. | Jul 2018 | A1 |
20180193090 | De et al. | Jul 2018 | A1 |
20180200497 | Mickelsen | Jul 2018 | A1 |
20180289417 | Schweitzer et al. | Oct 2018 | A1 |
20180303488 | Hill | Oct 2018 | A1 |
20180311497 | Viswanathan et al. | Nov 2018 | A1 |
20180344393 | Gruba et al. | Dec 2018 | A1 |
20180360534 | Teplitsky et al. | Dec 2018 | A1 |
20190038171 | Howard | Feb 2019 | A1 |
20190046791 | Ebbers et al. | Feb 2019 | A1 |
20190069950 | Viswanathan et al. | Mar 2019 | A1 |
20190125439 | Rohl et al. | May 2019 | A1 |
20190151015 | Viswanathan et al. | May 2019 | A1 |
20190183378 | Mosesov et al. | Jun 2019 | A1 |
20190209238 | Jimenez | Jul 2019 | A1 |
20190223938 | Arena et al. | Jul 2019 | A1 |
20190223950 | Gelbart et al. | Jul 2019 | A1 |
20190231421 | Viswanathan et al. | Aug 2019 | A1 |
20190233809 | Neal et al. | Aug 2019 | A1 |
20190256839 | Neal et al. | Aug 2019 | A1 |
20190269912 | Viswanathan et al. | Sep 2019 | A1 |
20190328445 | Sano et al. | Oct 2019 | A1 |
20190336198 | Viswanathan et al. | Nov 2019 | A1 |
20190336207 | Viswanathan | Nov 2019 | A1 |
20190376055 | Davalos et al. | Dec 2019 | A1 |
Number | Date | Country |
---|---|---|
1042990 | Oct 2000 | EP |
1125549 | Aug 2001 | EP |
0797956 | Jun 2003 | EP |
1340469 | Sep 2003 | EP |
1127552 | Jun 2006 | EP |
1803411 | Jul 2007 | EP |
1009303 | Jun 2009 | EP |
2213729 | Aug 2010 | EP |
2382935 | Nov 2011 | EP |
2425871 | Mar 2012 | EP |
2532320 | Dec 2012 | EP |
2587275 | May 2013 | EP |
2663227 | Nov 2013 | EP |
1909678 | Jan 2014 | EP |
2217165 | Mar 2014 | EP |
2376193 | Mar 2014 | EP |
2708181 | Mar 2014 | EP |
2777579 | Sep 2014 | EP |
2777585 | Sep 2014 | EP |
2934307 | Oct 2015 | EP |
3056242 | Aug 2016 | EP |
3111871 | Jan 2017 | EP |
3151773 | Apr 2018 | EP |
06-507797 | Sep 1994 | JP |
10-510745 | Oct 1998 | JP |
2000-508196 | Jul 2000 | JP |
2005-516666 | Jun 2005 | JP |
2006-506184 | Feb 2006 | JP |
2007-325935 | Dec 2007 | JP |
2008-538997 | Nov 2008 | JP |
2009-500129 | Jan 2009 | JP |
2011-509158 | Mar 2011 | JP |
2012-050538 | Mar 2012 | JP |
9207622 | May 1992 | WO |
9221278 | Dec 1992 | WO |
9221285 | Dec 1992 | WO |
9407413 | Apr 1994 | WO |
9724073 | Jul 1997 | WO |
9725917 | Jul 1997 | WO |
9737719 | Oct 1997 | WO |
9904851 | Feb 1999 | WO |
9922659 | May 1999 | WO |
9956650 | Nov 1999 | WO |
9959486 | Nov 1999 | WO |
0256782 | Jul 2002 | WO |
0353289 | Jul 2003 | WO |
0365916 | Aug 2003 | WO |
2004045442 | Jun 2004 | WO |
2004086994 | Oct 2004 | WO |
2005046487 | May 2005 | WO |
2006115902 | Nov 2006 | WO |
2007006055 | Jan 2007 | WO |
2007079438 | Jul 2007 | WO |
2009082710 | Jul 2009 | WO |
2009089343 | Jul 2009 | WO |
2009137800 | Nov 2009 | WO |
2010014480 | Feb 2010 | WO |
2011028310 | Mar 2011 | WO |
2011154805 | Dec 2011 | WO |
2012051433 | Apr 2012 | WO |
2012097067 | Jul 2012 | WO |
2012153928 | Nov 2012 | WO |
2013019385 | Feb 2013 | WO |
2014025394 | Feb 2014 | WO |
2014031800 | Feb 2014 | WO |
2014036439 | Mar 2014 | WO |
2014100579 | Jun 2014 | WO |
2014160832 | Oct 2014 | WO |
2015066322 | May 2015 | WO |
2015099786 | Jul 2015 | WO |
2015103530 | Jul 2015 | WO |
2015103574 | Jul 2015 | WO |
2015130824 | Sep 2015 | WO |
2015140741 | Sep 2015 | WO |
2015143327 | Sep 2015 | WO |
2015171921 | Nov 2015 | WO |
2015175944 | Nov 2015 | WO |
2015192018 | Dec 2015 | WO |
2015192027 | Dec 2015 | WO |
2016059027 | Apr 2016 | WO |
2016060983 | Apr 2016 | WO |
2016081650 | May 2016 | WO |
2016090175 | Jun 2016 | WO |
2017093926 | Jun 2017 | WO |
2017119934 | Jul 2017 | WO |
2017120169 | Jul 2017 | WO |
2017192477 | Nov 2017 | WO |
2017192495 | Nov 2017 | WO |
2017218734 | Dec 2017 | WO |
2018005511 | Jan 2018 | WO |
2018191149 | Oct 2018 | WO |
2018200800 | Nov 2018 | WO |
2019118436 | Jun 2019 | WO |
2019133606 | Jul 2019 | WO |
2019234133 | Dec 2019 | WO |
Entry |
---|
Du Pre, B.C. et al., “Minimal coronary artery damage by myocardial electroporation ablation,” Europace, 15(1):144-149 (2013). |
Hobbs, E. P., “Investor Relations Update: Tissue Ablation via Irreversible Electroporation (IRE),” Powerpoint (2004), 16 pages. |
Lavee, J. et al., “A Novel Nonthermal Energy Source for Surgical Epicardial Atrial Ablation: Irreversible Electroporation,” The Heart Surgery Forum #2006-1202, 10(2), 2007 [Epub Mar. 2007]. |
Madhavan, M. et al., “Novel Percutaneous Epicardial Autonomic Modulation in the Canine for Atrial Fibrillation: Results of an Efficacy and Safety Study,” Pace, 00:1-11 (2016). |
Neven, K. et al., “Epicardial linear electroporation ablation and lesion size,” Heart Rhythm, 11:1465-1470 (2014). |
Neven, K. et al., “Myocardial Lesion Size After Epicardial Electroporation Catheter Ablation After Subxiphoid Puncture,” Circ Arrhythm Electrophysiol., 7(4):728-733 (2014). |
Neven, K. et al., “Safety and Feasibility of Closed Chest Epicardial Catheter Ablation Using Electroporation,” Circ Arrhythm Electrophysiol., 7:913-919 (2014). |
Van Driel, V.J.H.M. et al., “Low vulnerability of the right phrenic nerve to electroporation ablation,” Heart Rhythm, 12:1838-1844 (2015). |
Van Driel, V.J.H.M. et al., “Pulmonary Vein Stenosis After Catheter Ablation Electroporation Versus Radiofrequency,” Circ Arrhythm Electrophysiol., 7(4):734-738 (2014). |
Wittkampf, F.H. et al., “Feasibility of Electroporation for the Creation of Pulmonary Vein Ostial Lesions,” J Cardiovasc Electrophysiol, 22(3):302-309 (Mar. 2011). |
Wittkampf, F.H. et al., “Myocardial Lesion Depth With Circular Electroporation Ablation,” Circ. Arrhythm Electrophysiol., 5(3):581-586 (2012). |
Number | Date | Country | |
---|---|---|---|
20220000547 A1 | Jan 2022 | US |
Number | Date | Country | |
---|---|---|---|
61996855 | May 2014 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 15795075 | Oct 2017 | US |
Child | 17207053 | US | |
Parent | 15341523 | Nov 2016 | US |
Child | 15795075 | US | |
Parent | PCT/US2015/031086 | May 2015 | WO |
Child | 15341523 | US |